Summary of the Study: Social Determinants of Health and Hypertrophic Cardiomyopathy (HCM) Outcomes
This article discusses a study published in JAMA Cardiology investigating the link between social determinants of health (SDOH) and outcomes in patients with hypertrophic cardiomyopathy (HCM). Here’s a breakdown of the key findings:
Key Findings:
* Lower income & Higher Social Deprivation = Worse Outcomes: patients with HCM living in areas with lower household income or higher social Deprivation Index (SDI) scores had substantially worse cardiovascular outcomes.
* Increased Risk of Heart Failure: Those in the lowest-income areas had more than twice the risk of heart failure compared too those in the highest-income areas.
* Increased Risk of Composite Outcome: individuals in lower-income areas also had a 52% higher risk of a composite outcome including ventricular arrhythmias, heart failure, atrial fibrillation, stroke, and death.
* SDI Impact: Residence in the most socially deprived areas was associated with increased risks of heart failure, ventricular arrhythmias, and the overall composite outcome.
* Genetic Condition, Environmental Influence: The study highlights that even in a genetically driven condition like HCM, social and environmental factors play a significant role in disease progression.
Study Details:
* Study Type: Multicenter, prospective cohort study.
* Participants: 4431 US adults with HCM.
* Data Collection: Data was collected between 2015 and march 2024, analyzed through June 2025.
* SDOH Measures: Median household income and the Social Deprivation Index (SDI) were used to assess area-based SDOH.
* Follow-up: Median follow-up of 2.15 years.
Limitations:
* Zip Code Level data: Using zip code-level SDOH may not capture nuanced neighborhood or individual differences.
* US-Specific: The study only included US adults, limiting generalizability.
* Single time Point: Data reflected a single point in time,not changes over time.
* Potential Underestimation: Adjusting for clinical risk factors may have underestimated the true impact of SDOH.
Conclusion:
The researchers conclude that where someone lives can influence clinical outcomes in HCM, even with a strong genetic component. Incorporating SDOH into risk assessment could help identify high-risk patients and improve outcomes.
Links to Sources:
* JAMA Cardiology Study: https://jamanetwork.com/journals/jamacardiology/fullarticle/2843430?resultClick=24
* Cleveland Clinic – Hypertrophic Cardiomyopathy: https://my.clevelandclinic.org/health/diseases/17116-hypertrophic-cardiomyopathy
